BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Other News

Celsion drug delivery, cancer news

Investor Mangrove Partners Fund L.P. sent a letter to Celsion's board requesting several actions including the immediate appointment of two Mangrove designees to Celsion's board. Mangrove, which holds a 7.85% stake, also requested Celsion hire an independent investment bank to explore all strategic alternatives, set measurable goals for management that carry...

Read the full 234 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >